Fig. 3From: Real-world use of ceftolozane/tazobactam: a systematic literature reviewP. aeruginosa resistance profile in studies identified in 2015–2017 and 2018–2020. MDR: Multidrug-resistant; PDR: Pandrug-resistant; XDR: Extensively-drug-resistantBack to article page